ZNF423 is critically required for retinoic acid-induced differentiation and is a marker of neuroblastoma outcome.

Retinoids play key roles in differentiation, growth arrest, and apoptosis and are increasingly being used in the clinic for the treatment of a variety of cancers, including neuroblastoma. Here, using a large-scale RNA interference-based genetic screen, we identify ZNF423 (also known as Ebfaz, OAZ, or Zfp423) as a component critically required for retinoic acid (RA)-induced differentiation. ZNF423 associates with the RARalpha/RXRalpha nuclear receptor complex and is essential for transactivation in response to retinoids. Downregulation of ZNF423 expression by RNA interference in neuroblastoma cells results in a growth advantage and resistance to RA-induced differentiation, whereas overexpression of ZNF423 leads to growth inhibition and enhanced differentiation. Finally, we show that low ZNF423 expression is associated with poor disease outcome in neuroblastoma patients.

[1]  E. Bogenmann,et al.  The RET and TRKA pathways collaborate to regulate neuroblastoma differentiation , 2004, Oncogene.

[2]  S. Minucci,et al.  Fusion proteins of the retinoic acid receptor-α recruit histone deacetylase in promyelocytic leukaemia , 1998, Nature.

[3]  Thorsten Heinzel,et al.  Ligand-independent repression by the thyroid hormone receptor mediated by a nuclear receptor co-repressor , 1995, Nature.

[4]  S. Chittur,et al.  Global gene expression profiles associated with retinoic acid‐induced differentiation of embryonal carcinoma cells , 2006, Molecular reproduction and development.

[5]  Antonio Ortega,et al.  Prognostic significance of gene expression profiles of metastatic neuroblastomas lacking MYCN gene amplification. , 2006, Journal of the National Cancer Institute.

[6]  R. Y. Tsai,et al.  Cloning and Functional Characterization of Roaz, a Zinc Finger Protein that Interacts with O/E-1 to Regulate Gene Expression: Implications for Olfactory Neuronal Development , 1997, The Journal of Neuroscience.

[7]  M. Maden.  Retinoid signalling in the development of the central nervous system , 2002, Nature Reviews Neuroscience.

[8]  R. Y. Tsai,et al.  Identification of DNA Recognition Sequences and Protein Interaction Domains of the Multiple-Zn-Finger Protein Roaz , 1998, Molecular and Cellular Biology.

[9]  R. T. Proffitt,et al.  Comparison of 13-cis-retinoic acid to trans-retinoic acid using human neuroblastoma cell lines. , 1994, Progress in clinical and biological research.

[10]  R. Reed,et al.  Zfp423/OAZ Participates in a Developmental Switch during Olfactory Neurogenesis , 2007, Neuron.

[11]  Anna Lagergren,et al.  Olf/EBF proteins are expressed in neuroblastoma cells: Potential regulators of the Chromogranin A and SCG10 promoters , 2004, International journal of cancer.

[12]  V. Sumantran,et al.  BMP-6 and retinoic acid synergistically differentiate the IMR-32 human neuroblastoma cells. , 2003, Anticancer research.

[13]  K. Guan,et al.  Induction of Cellular Differentiation by Retinoic Acid in vitro , 1999, Cells Tissues Organs.

[14]  L. Cerchia,et al.  A Cross-Talk between TrkB and Ret Tyrosine Kinases Receptors Mediates Neuroblastoma Cells Differentiation , 2008, PloS one.

[15]  C. Tribioli,et al.  Distinct interactions of PML-RARalpha and PLZF-RARalpha with co-repressors determine differential responses to RA in APL. , 1998, Nature genetics.

[16]  A. Nakagawara,et al.  Accumulation of p27 KIP1 is associated with BMP2-induced growth arrest and neuronal differentiation of human neuroblastoma-derived cell lines. , 2003, Biochemical and biophysical research communications.

[17]  Yohko Nakamura,et al.  Accumulation of p27KIP1 is associated with BMP2-induced growth arrest and neuronal differentiation of human neuroblastoma-derived cell lines , 2003 .

[18]  P. Chambon,et al.  TIF2, a 160 kDa transcriptional mediator for the ligand‐dependent activation function AF‐2 of nuclear receptors. , 1996, The EMBO journal.

[19]  Nir Hacohen,et al.  Minimizing the risk of reporting false positives in large-scale RNAi screens , 2006, Nature Methods.

[20]  Lucia Altucci,et al.  The promise of retinoids to fight against cancer , 2001, Nature Reviews Cancer.

[21]  Rogier Versteeg,et al.  Biological effects of TrkA and TrkB receptor signaling in neuroblastoma. , 2005, Cancer letters.

[22]  R. Bernards,et al.  The Human Tumor Antigen PRAME Is a Dominant Repressor of Retinoic Acid Receptor Signaling , 2005, Cell.

[23]  M. Crossley,et al.  Mammalian Krüppel-like transcription factors: more than just a pretty finger. , 1999, Trends in biochemical sciences.

[24]  Weihua Ni,et al.  OAZ Regulates Bone Morphogenetic Protein Signaling through Smad6 Activation* , 2006, Journal of Biological Chemistry.

[25]  K. Umesono,et al.  The nuclear receptor superfamily: The second decade , 1995, Cell.

[26]  D. Kaplan,et al.  Induction of TrkB by retinoic acid mediates biologic responsiveness to BDNF and differentiation of human neuroblastoma cells , 1993, Neuron.

[27]  C. Glass,et al.  A Corepressor/Coactivator Exchange Complex Required for Transcriptional Activation by Nuclear Receptors and Other Regulated Transcription Factors , 2004, Cell.

[28]  P. Chambon,et al.  F9 embryocarcinoma cells: a cell autonomous model to study the functional selectivity of RARs and RXRs in retinoid signaling. , 2001, Histology and histopathology.

[29]  E. Dmitrovsky,et al.  Retinoids in cancer therapy and chemoprevention: promise meets resistance , 2003, Oncogene.

[30]  K K Matthay,et al.  Treatment of High-Risk Neuroblastoma with Intensive Chemotherapy, Radiotherapy, Autologous Bone Marrow Transplantation, and 13-cis-Retinoic Acid , 1999 .

[31]  Holger Christiansen,et al.  Loss of a FYN-regulated differentiation and growth arrest pathway in advanced stage neuroblastoma. , 2002, Cancer cell.

[32]  John H. White,et al.  Ligand-dependent nuclear receptor corepressor LCoR functions by histone deacetylase-dependent and -independent mechanisms. , 2003, Molecular cell.

[33]  K. Matthay,et al.  Retinoid therapy of high-risk neuroblastoma. , 2003, Cancer letters.

[34]  R. Bernards,et al.  A System for Stable Expression of Short Interfering RNAs in Mammalian Cells , 2002, Science.

[35]  N. Copeland,et al.  Zfp423 Is Required for Normal Cerebellar Development , 2006, Molecular and Cellular Biology.

[36]  C. Tribioli,et al.  Distinct interactions of PML-RARα and PLZF-RARα with co-repressors determine differential responses to RA in APL , 1998, Nature Genetics.

[37]  R. Bernards,et al.  A functional genetic screen identifies retinoic acid signaling as a target of histone deacetylase inhibitors , 2007, Proceedings of the National Academy of Sciences.

[38]  R. Evans,et al.  A transcriptional co-repressor that interacts with nuclear hormone receptors , 1995, Nature.

[39]  M. Maden,et al.  Too much of a good thing: retinoic acid as an endogenous regulator of neural differentiation and exogenous teratogen , 2003, The European journal of neuroscience.

[40]  R. Evans,et al.  Nuclear Receptor Coactivator ACTR Is a Novel Histone Acetyltransferase and Forms a Multimeric Activation Complex with P/CAF and CBP/p300 , 1997, Cell.

[41]  B. O’Malley,et al.  Sequence and Characterization of a Coactivator for the Steroid Hormone Receptor Superfamily , 1995, Science.

[42]  Reuven Agami,et al.  A large-scale RNAi screen in human cells identifies new components of the p53 pathway , 2004, Nature.

[43]  Jiangyang Zhang,et al.  The transcription factor Zfp423/OAZ is required for cerebellar development and CNS midline patterning. , 2007, Developmental biology.

[44]  G. Brodeur.  Neuroblastoma: biological insights into a clinical enigma , 2003, Nature Reviews Cancer.

[45]  J. Massagué,et al.  OAZ Uses Distinct DNA- and Protein-Binding Zinc Fingers in Separate BMP-Smad and Olf Signaling Pathways , 2000, Cell.

[46]  M. Haussler,et al.  Effects of retinoic acid (RA) on the growth and phenotypic expression of several human neuroblastoma cell lines. , 1983, Experimental cell research.

[47]  S. Lippman,et al.  Anti-retinoic acid (RA) antibody binding to human premalignant oral lesions, which occurs less frequently than binding to normal tissue, increases after 13-cis-RA treatment in vivo and is related to RA receptor beta expression. , 1995, Cancer research.

[48]  R. Bernards,et al.  Plasminogen activator inhibitor-1 is a critical downstream target of p53 in the induction of replicative senescence , 2006, Nature Cell Biology.

[49]  P. Kushner,et al.  Nuclear factor RIP140 modulates transcriptional activation by the estrogen receptor. , 1995, The EMBO journal.

[50]  Neil J. McKenna,et al.  Combinatorial Control of Gene Expression by Nuclear Receptors and Coregulators , 2002, Cell.

[51]  W. Gerald,et al.  Integrative genomics identifies distinct molecular classes of neuroblastoma and shows that multiple genes are targeted by regional alterations in DNA copy number. , 2006, Cancer research.

[52]  P. Chambon.  A decade of molecular biology of retinoic acid receptors , 1996, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.